Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL™ and BOOSTRIX®

NCT00319553 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00319553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00319553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL™ and BOOSTRIX®
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
December 31, 2008
Enrollment
647 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, pertussis, tetanus